Client News

Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Mallia Innovations Secures €3 Million Financing to Accelerate Commercial Expansion of the 8T3 Essentials Line

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Abivax Announces Launch of Public Offering of American Depositary Shares

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

smartbax secures additional financing to advance lead antibiotic program to IND filing

Epitome Therapeutics Launches with €4 Million in Total Funding Following Oversubscribed Pre-Seed Round

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Andera Partners joins the European Life Sciences Coalition (ELSC) with the aim to support the mobilization of capital for life sciences innovation in Europe

Darwin AG Announces Results of the 2026 Annual General Meeting